StockNews.com lowered shares of NeoGenomics (NASDAQ:NEO – Get Rating) from a hold rating to a sell rating in a research note published on Friday. A number of other equities analysts have also issued reports on the stock. Cowen raised their target price on shares of NeoGenomics from $14.00 to $20.00 and gave the stock an […]
Related Keywords
Piper Sandler , Clinical Services , Needham Company , Neogenomics Inc , Bessemer Group Inc , Morgan Stanley , Ronald Blue Trust Inc , Quadrant Capital Group , Pharma Services , Get Rating , Moderate Buy , Genomics Trading Down , Capital Group , Blue Trust , Financial Advisors , Bessemer Group , Neogenomics Daily , Neogenomics , Nasdaq Neo , Neo , Medical , Downgrade , Stocknews Com ,
comparemela.com © 2020. All Rights Reserved.